Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Assessing the Value of Time Series Real-World and Clinical Trial Data vs. Baseline-Only Data in Predicting Responses to Pregabalin Therapy for Patients with Painful Diabetic Peripheral Neuropathy.

Alexander J Jr, Edwards RA, Brodsky M, Savoldelli A, Manca L, Grugni R, Emir B, Whalen E, Watt S, Parsons B.

Clin Drug Investig. 2019 Aug;39(8):775-786. doi: 10.1007/s40261-019-00812-6.

PMID:
31243706
2.

Using time series analysis approaches for improved prediction of pain outcomes in subgroups of patients with painful diabetic peripheral neuropathy.

Alexander J Jr, Edwards RA, Brodsky M, Manca L, Grugni R, Savoldelli A, Bonfanti G, Emir B, Whalen E, Watt S, Parsons B.

PLoS One. 2018 Dec 6;13(12):e0207120. doi: 10.1371/journal.pone.0207120. eCollection 2018. Erratum in: PLoS One. 2019 Feb 26;14(2):e0212959.

3.

Integrating data from randomized controlled trials and observational studies to predict the response to pregabalin in patients with painful diabetic peripheral neuropathy.

Alexander J, Edwards RA, Savoldelli A, Manca L, Grugni R, Emir B, Whalen E, Watt S, Brodsky M, Parsons B.

BMC Med Res Methodol. 2017 Jul 20;17(1):113. doi: 10.1186/s12874-017-0389-2.

4.

Dose Titration of Pregabalin in Patients with Painful Diabetic Peripheral Neuropathy: Simulation Based on Observational Study Patients Enriched with Data from Randomized Studies.

Alexander J Jr, Edwards RA, Manca L, Grugni R, Bonfanti G, Emir B, Whalen E, Watt S, Parsons B.

Adv Ther. 2018 Mar;35(3):382-394. doi: 10.1007/s12325-018-0664-6. Epub 2018 Feb 23.

PMID:
29476444
5.

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.

Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE.

J Pain. 2005 Apr;6(4):253-60.

PMID:
15820913
6.

Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: A randomized placebo-controlled trial.

Mu Y, Liu X, Li Q, Chen K, Liu Y, Lv X, Xu X, Fan D, Shang N, Yang R, Pauer L, Pan C.

J Diabetes. 2018 Mar;10(3):256-265. doi: 10.1111/1753-0407.12585. Epub 2017 Nov 1.

PMID:
28727270
7.

Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial.

Simpson DM, Schifitto G, Clifford DB, Murphy TK, Durso-De Cruz E, Glue P, Whalen E, Emir B, Scott GN, Freeman R; 1066 HIV Neuropathy Study Group.

Neurology. 2010 Feb 2;74(5):413-20. doi: 10.1212/WNL.0b013e3181ccc6ef.

8.

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial.

Lesser H, Sharma U, LaMoreaux L, Poole RM.

Neurology. 2004 Dec 14;63(11):2104-10.

PMID:
15596757
9.

Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.

Moon DE, Lee DI, Lee SC, Song SO, Yoon DM, Yoon MH, Kim HK, Lee YW, Kim C, Lee PB.

Clin Ther. 2010 Dec;32(14):2370-85. doi: 10.1016/j.clinthera.2011.01.014.

PMID:
21353106
10.

Prediction of pregabalin-mediated pain response by severity of sleep disturbance in patients with painful diabetic neuropathy and post-herpetic neuralgia.

Vinik A, Emir B, Parsons B, Cheung R.

Pain Med. 2014 Apr;15(4):661-70. doi: 10.1111/pme.12310. Epub 2013 Dec 11.

PMID:
24330406
11.

Pregabalin in patients with inadequately treated painful diabetic peripheral neuropathy: a randomized withdrawal trial.

Raskin P, Huffman C, Toth C, Asmus MJ, Messig M, Sanchez RJ, Pauer L.

Clin J Pain. 2014 May;30(5):379-90. doi: 10.1097/AJP.0b013e31829ea1a1.

PMID:
23887339
12.

Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial.

Satoh J, Yagihashi S, Baba M, Suzuki M, Arakawa A, Yoshiyama T, Shoji S.

Diabet Med. 2011 Jan;28(1):109-16. doi: 10.1111/j.1464-5491.2010.03152.x.

PMID:
21166852
13.

A cost-utility comparison of four first-line medications in painful diabetic neuropathy.

O'Connor AB, Noyes K, Holloway RG.

Pharmacoeconomics. 2008;26(12):1045-64. doi: 10.2165/0019053-200826120-00007.

PMID:
19014205
14.

Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial.

Arezzo JC, Rosenstock J, Lamoreaux L, Pauer L.

BMC Neurol. 2008 Sep 16;8:33. doi: 10.1186/1471-2377-8-33.

15.
16.

The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials.

Roth T, van Seventer R, Murphy TK.

Curr Med Res Opin. 2010 Oct;26(10):2411-9. doi: 10.1185/03007995.2010.516142. Review.

PMID:
20812792
17.

Pregabalin for neuropathic pain in adults.

Derry S, Bell RF, Straube S, Wiffen PJ, Aldington D, Moore RA.

Cochrane Database Syst Rev. 2019 Jan 23;1:CD007076. doi: 10.1002/14651858.CD007076.pub3.

PMID:
30673120
18.

Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy Using an NSAID for Other Pain Conditions: A Double-Blind Crossover Study.

Raskin P, Huffman C, Yurkewicz L, Pauer L, Scavone JM, Yang R, Parsons B.

Clin J Pain. 2016 Mar;32(3):203-10. doi: 10.1097/AJP.0000000000000254.

PMID:
25968451
19.

Predictive Modeling of Response to Pregabalin for the Treatment of Neuropathic Pain Using 6-Week Observational Data: A Spectrum of Modern Analytics Applications.

Emir B, Johnson K, Kuhn M, Parsons B.

Clin Ther. 2017 Jan;39(1):98-106. doi: 10.1016/j.clinthera.2016.11.015. Epub 2016 Dec 20.

20.

Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation.

Carlos F, Espejel L, Novick D, L├│pez R, Flores D.

Medwave. 2015 Sep 25;15(8):e6265. doi: 10.5867/medwave.2015.08.6265. English, Spanish.

PMID:
26460688

Supplemental Content

Support Center